Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

Serevent (Salmeterol Xinafoate Inhalation) Diskus
Company:  Glaxo Wellcome Inc.
Application No.:  20-692S1,2
Approval Date: 9/15/1998


Date created: September 10, 2001

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.